...
首页> 外文期刊>Journal of Advanced Pharmaceutical Technology Research >Patency and outcomes of tunneled hemodialysis catheter via femoral versus jugular vein access
【24h】

Patency and outcomes of tunneled hemodialysis catheter via femoral versus jugular vein access

机译:通过股静脉和颈静脉通路的隧道式血液透析导管的通畅性和结局

获取原文
           

摘要

The design of a suitable catheter to achieve a permanent, economical, and efficient vascular pathway for hemodialysis has been always accompanied by difficult and potential complications. Various strategies have been adopted to minimize the use of tunneled catheters that are used for dialysis. Regarding this, the present study aimed to assess the success, patency, as well as early and late complications of cuffed femoral and jugular hemodialysis catheters. This case–control study was performed on 145 hemodialysis patients who were candidates for the insertion of tunneled hemodialysis catheters at Rasoul-e-Akram Hospital in Tehran, Iran, during 2015–2016. The data were collected retrospectively by reviewing the patients' medical records. The participants were divided into two groups of femoral and jugular accesses, based on the type of catheter they had. To determine the procedure-related outcomes, they were assessed 1 week, 1 month, and 6 months after catheterization. According to the results, the mean times of catheter efficacy (patency) were 4.43 ± 3.11 and 5.65 ± 4.57 months in the femoral and jugular access groups, respectively, showing no significant difference between the two groups (P = 0.095). Furthermore, the femoral and jugular access groups had the infection prevalence of 23.2% and 16.2%, thrombosis prevalence of 28.6% and 20.9%, and mortality rates of 3.5% and 1.4%, respectively. According to the multivariable linear regression model, the history of catheterization could predict reduced catheter patency. In addition, catheter-related infection could be predicted among females based on the multivariate logistic regression analysis. As the findings indicated, femoral and jugular hemodialysis catheter insertions showed no significant difference in terms of the mean patency, complications (e.g., infection and thrombosis), and mortality rate.
机译:为了实现用于血液透析的永久,经济和有效的血管通路的合适导管的设计一直伴随着困难和潜在的并发症。已经采取了各种策略来最小化用于透析的隧道导管的使用。关于这一点,本研究旨在评估袖带式股和颈静脉血液透析导管的成功率,通畅性以及早期和晚期并发症。这项病例对照研究是针对2015年至2016年期间在伊朗德黑兰的Rasoul-e-Akram医院接受145例血液透析导管插入的血液透析患者进行的。通过回顾患者的病历回顾性收集数据。根据参与者的导管类型,将他们分为两组,股骨和颈动脉入路。为了确定与手术相关的结局,在插管后1周,1个月和6个月对它们进行了评估。根据结果​​,在股骨和颈静脉入路组中,导管功效(通畅)的平均时间分别为4.43±3.11和5.65±4.57个月,两组之间无显着差异(P = 0.095)。此外,股动脉和颈静脉进入组的感染率分别为23.2%和16.2%,血栓形成率为28.6%和20.9%,死亡率分别为3.5%和1.4%。根据多变量线性回归模型,导管插入的历史可以预测导管通畅程度的降低。此外,基于多元逻辑回归分析,可以预测女性中与导管相关的感染。如发现所表明的那样,在平均通畅性,并发症(例如感染和血栓形成)和死亡率方面,股和颈静脉血液透析导管的插入没有显着差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号